Radcliffe Capital Management’s Biotech Acquisition Company Class A Ordinary Shares BIOT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-456,764
| Closed | -$4.61M | – | 860 |
|
|
2022
Q4 | $4.61M | Hold |
456,764
| – | – | 0.15% | 214 |
|
|
2022
Q3 | $4.53M | Buy |
456,764
+50,864
| +13% | +$505K | 0.11% | 310 |
|
|
2022
Q2 | $4.02M | Hold |
405,900
| – | – | 0.09% | 363 |
|
|
2022
Q1 | $4M | Hold |
405,900
| – | – | 0.09% | 335 |
|
|
2021
Q4 | $3.99M | Hold |
405,900
| – | – | 0.1% | 266 |
|
|
2021
Q3 | $3.95M | Hold |
405,900
| – | – | 0.12% | 239 |
|
|
2021
Q2 | $3.93M | Buy |
+405,900
| New | +$3.93M | 0.12% | 258 |
|